There has been a reported breakthrough in the race to develop a Covid-19 vaccine by scientists at Oxford University. An immune response to the new vaccine called ChAdOx1 nCoV-19 has indicated a strong “double defence”, whereby both antibodies and “killer” T-cells were reported to have been present in blood samples from volunteers in the first human phase of testing. The information was provided to The Telegraph by a senior source. Further media coverage will be reported on these developments on Monday 20th July.
 logo final copy.png)
The Hippocratic Editorial and VT team. Please send your suggestions to [email protected]
Latest posts by Hippocratic Post (see all)
- Shake-up of services needed to ease fibromyalgia pain - 9th December 2025
- Continuous glucose monitoring reduces risk of excessive birth weight - 9th December 2025
- Significant mental health benefits of adult-worn slings - 9th December 2025
